By Josh White
Date: Wednesday 24 Apr 2024
(Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by expanded hospital deployments of 'Steriwave'.
By Josh White
Date: Tuesday 05 Mar 2024
(Sharecast News) - Ondine Biomedical announced on Tuesday that it is joining forces with the Mid Yorkshire Teaching NHS Trust, Health Innovation Yorkshire and Humber, and the York Health Economics Consortium (YHEC) to assess the potential cost savings associated with using its 'Steriwave' technology.
By Josh White
Date: Wednesday 13 Dec 2023
(Sharecast News) - Life sciences company Ondine Biomedical has successfully raised CAD 4.91m ($3.62m), it announced on Wednesday, bolstering its efforts to commercialise its photodisinfection technology aimed at reducing healthcare-associated infections (HAIs).
Currency | UK Pounds |
Share Price | 5.88p |
Change Today | -0.38p |
% Change | -6.00 % |
52 Week High | 19.00 |
52 Week Low | 5.50 |
Volume | 431,829 |
Shares Issued | 226.75m |
Market Cap | £13.32m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:23 | 200,000 @ 5.75p |
16:03 | 2,300 @ 5.80p |
15:20 | 85 @ 5.50p |
15:03 | 42,683 @ 5.84p |
14:28 | 620 @ 6.00p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research